Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer.
about
Elisidepsin Interacts Directly with Glycosylceramides in the Plasma Membrane of Tumor Cells to Induce Necrotic Cell DeathA new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosisRe-configuration of sphingolipid metabolism by oncogenic transformation.Glucosylceramide synthase, a factor in modulating drug resistance, is overexpressed in metastatic breast carcinomaCeramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies.Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristicsDoxorubicin influences the expression of glucosylceramide synthase in invasive ductal breast cancerAltered methylation of glucosylceramide synthase promoter regulates its expression and associates with acquired multidrug resistance in invasive ductal breast cancer.Expression of glucosylceramide synthase in invasive ductal breast cancer may be correlated with high estrogen receptor status and low HER-2 statusMDR1 (multidrug resistence 1) can regulate GCS (glucosylceramide synthase) in breast cancer cells.Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer.The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60: acute myeloid leukemia cells.Regulation of lipid metabolism in breast cancer provides diagnostic and therapeutic opportunities
P2860
Q27312540-7FBE9A43-D12F-4D47-8D5A-C870EFC20C01Q28476087-B050DFAD-83B8-476B-94A4-22D3310C0C57Q33649823-D0847DBE-F454-4107-ADAD-899608A051E7Q33683147-B038E222-E72C-421C-8ED8-4E0C980C250AQ33733991-8B46E56F-859B-4882-8FE4-C99F1536F280Q33984087-D8459090-C4A1-4679-9781-9F1B28A3BB03Q33991690-A9E0F86D-88C7-4FBF-B003-6BEF4B05900AQ34267466-C450E17C-178F-4654-A1C3-6A684A8106FAQ34469733-7CC2B8E8-D672-4B8E-B534-7E5239B3BB84Q37392829-5F5AB6DC-6F0F-4021-857B-8A212769CB5DQ37685348-896B253D-8C36-4B70-9899-E08588DDA6D1Q39549312-1A843F60-DD38-4B6B-BE44-628546A3717EQ41135883-33306B93-00F4-4EF4-AE2B-30AAB131FC3DQ43094374-E135683B-D0F1-48ED-B99C-F04FA183EC68Q57012149-E70BF139-48C7-49FB-922C-97524226EA6D
P2860
Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer.
@en
Prognostic relevance of glucosylceramide synthase
@nl
type
label
Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer.
@en
Prognostic relevance of glucosylceramide synthase
@nl
prefLabel
Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer.
@en
Prognostic relevance of glucosylceramide synthase
@nl
P2093
P2860
P1476
Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer.
@en
P2093
Achim Rody
Dirk Metzler
Eugen Ruckhäberle
Lars Hanker
Manfred Kaufmann
Regine Gätje
Uwe Holtrich
P2860
P2888
P356
10.1007/S00432-008-0436-9
P50
P577
2008-06-17T00:00:00Z